Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

Hong Kong · Delayed Price · Currency is HKD

6.37

-0.02 (-0.31%)

Apr 21, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Chemical Raw Materials	2.66B	2.75B	3.15B	3.19B	2.76B
Chemical Raw Materials Growth	-3.32%	-12.60%	-1.37%	15.71%	4.59%
Offset	-1.89B	-2.05B	-1.86B	-1.79B	-1.63B
Pharmaceutical Intermediates and Other Products	3.13B	2.55B	2.26B	2.11B	2.12B
Pharmaceutical Intermediates and Other Products Growth	22.92%	12.76%	7.01%	-0.13%	39.81%
Preparations	4.85B	5.21B	4.56B	3.99B	3.31B
Preparations Growth	-6.92%	14.49%	14.23%	20.36%	-0.05%
Total	8.75B	8.47B	8.10B	7.50B	6.56B
Total Growth	3.41%	4.51%	7.97%	14.37%	9.23%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China (Including Hong Kong)	6.79B	6.33B	5.93B	-	-
China (Including Hong Kong) Growth	7.15%	6.72%	-	-	-
Americas	745.57M	921.44M	763.82M	-	-
Americas Growth	-19.09%	20.63%	-	-	-
Europe	712.82M	798.42M	1.02B	-	-
Europe Growth	-10.72%	-22.02%	-	-	-
Others	511.11M	414.25M	379.69M	-	-
Others Growth	23.38%	9.10%	-	-	-
Total	8.75B	8.47B	8.10B	-	-
Total Growth	3.41%	4.51%	-	-	-

Source: S&P Global Market Intelligence.